Montgomery, Kristen R <br/><br/>
Elevated MeCP2 in Mice Causes Neurodegeneration Involving Tau Dysregulation and Excitotoxicity: Implications for the Understanding and Treatment of MeCP2 Triplication Syndrome.  [electronic resource] 

 -  Molecular neurobiology  Dec 2018 
 - 9057-9074 p.  digital 
<br/><br/> Publication Type: Journal Article 
<br/><br/><label>ISSN: </label>1559-1182 
<br/><br/><label>Standard No.: </label>10.1007/s12035-018-1046-4  doi 
<br/><br/><label>Subjects--Topical Terms: </label><br/>Animals<br/>Apoptosis--drug effects<br/>Astrocytes--drug effects<br/>Brain--metabolism<br/>Caspase 3--metabolism<br/>Culture Media, Conditioned--pharmacology<br/>Female<br/>Gene Expression Regulation--drug effects<br/>Male<br/>Methyl-CpG-Binding Protein 2--metabolism<br/>Mice, Transgenic<br/>Models, Biological<br/>Nerve Degeneration--genetics<br/>Nerve Tissue Proteins--metabolism<br/>Neurons--drug effects<br/>Neurotoxins--toxicity<br/>RNA, Messenger--genetics<br/>Spinal Cord--metabolism<br/>Syndrome<br/>Up-Regulation--drug effects<br/>tau Proteins--metabolism